Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
about
Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring StudyQ28834070Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.A at single nucleotide polymorphism-358 is required for G at -420 to confer the highest plasma resistin in the general Japanese populationAssociation of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients.Serum resistin positively correlates with serum lipids, but not with insulin resistance, in first-degree relatives of type-2 diabetes patients: an observational study in China.Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men.Human resistin: found in translation from mouse to manAssociation of the resistin gene promoter region polymorphism with Kawasaki disease in Chinese children.Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels.Plasma resistin is associated with single nucleotide polymorphisms of a possible resistin receptor, the decorin gene, in the general Japanese population.Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.Review article: The role of adipose tissue in uraemia-related insulin resistance.Relevance Study on Cerebral Infarction and Resistin Gene Polymorphism in Chinese Han Population.Resistin in rodents and humans.Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study.The role of adipokines in ischemic stroke risk stratification.Human resistin and the RELM of Inflammation in diabesity.The G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population.Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis.Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease.An inverse association between serum resistin levels and n-3 polyunsaturated fatty acids intake was strongest in the SNP-420 G/G genotype in the Japanese cohort: The Toon Genome Study.Resistin gene polymorphisms are associated with acne and serum lipid levels, providing a potential nexus between lipid metabolism and inflammation.PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population.Genome-wide association study of plasma resistin levels identified rs1423096 and rs10401670 as possible functional variants in the Japanese population.
P2860
Q28755370-B42EA083-B138-4E02-90D8-72A2FE5A0E22Q28834070-10AEAE03-8597-4B83-920E-8C04F20993CEQ30382436-8C1A69EB-7DBE-4D46-BAB3-EF0F180D81E2Q33543084-4DC0771F-5896-4DAA-819C-FF3963670CA8Q33558377-174AB947-699F-4697-9B68-92ADDFB9FFC5Q33606147-6AFCF875-219E-4EC9-9BF2-4798CDB4AD3BQ34352731-AF9B6B32-191A-446F-9E01-D6866B524EF4Q35087560-5A84D562-22EE-46AA-992A-8F3D7D5E9830Q35915520-B374D85A-064A-4C32-80E6-0F49C39302F0Q36317713-B233A0BD-B9F7-4D60-8D18-492B88D59876Q36560602-C950CA91-B97F-47D6-A3FB-D6585CB53549Q37111330-29EB22B6-DD01-4992-B521-9CCDA1A04639Q37112231-7A55EC72-4036-4CF3-87FC-DCB8FB7F4601Q37282784-C6A352AB-71F9-4721-B8B3-35AF6C91BC58Q37284283-E99CBBA1-EF52-4475-AA28-C1DA416BFA2BQ37435682-30298200-22F2-4BAE-BABD-211359DDD590Q37465684-34B17112-20A4-4083-BFC3-B57B42D20DD3Q38732089-36EFAC2D-1BFC-4741-8820-96669546E1CBQ42416828-0FE5C2DA-4B24-4D66-962E-1BB91A630A84Q42820222-E02B8913-8390-4800-954A-B269CFB13FF0Q43281626-06C0AE55-35D8-498C-A8AB-4100D3556900Q43515425-CB1131BD-B8B0-4D6F-8C05-500349350223Q46849188-AE70F31C-2704-40DB-AF76-F44EB335EB68Q46959457-0B68481B-5AF3-4936-AC3D-270CD93E0E75Q48051356-0B7088DF-FBC8-4EBC-A486-75BDF28E94DBQ50234954-12835EFA-7071-4ABA-A5A1-01B63440E5C1Q51127825-2DB68BF8-66BC-4488-9564-DC18489359ADQ51467648-FE116082-1CBF-461B-966A-A44BD7BFD1FE
P2860
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@en
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@nl
type
label
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@en
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@nl
prefLabel
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@en
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@nl
P2093
P1476
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
@en
P2093
Akiko Murakami
Fumiko Tanabe
Haruhiko Osawa
Hideichi Makino
Hiroshi Onuma
Ikki Shimizu
Jun Ohashi
Junko Yamauchi
Kazuya Yamada
Kenichi Kato
P304
P356
10.1016/J.BBRC.2005.07.122
P407
P577
2005-09-01T00:00:00Z